Stay updated on Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.

Latest updates to the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedFooter updates: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe header shows Revision: v3.3.2 instead of v3.2.0, indicating a routine site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoval of the government funding notice banner from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments to the History page; the content and ordering of the version entries remain the same. No substantive changes to study data, status, or outcomes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check97 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference11%

- Check104 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.